Heart Failure with Reduced Ejection Fraction: The Role of Cardiovascular and Lung Ultrasound beyond Ejection Fraction.

Syuzanna Shahnazaryan, Sergey Pepoyan, Hamayak Sisakian
Author Information
  1. Syuzanna Shahnazaryan: Clinic of General and Invasive Cardiology, "Heratsi" Hospital Complex #1, Yerevan State Medical University, 2 Koryun Street, Yerevan 375025, Armenia. ORCID
  2. Sergey Pepoyan: Clinic of General and Invasive Cardiology, "Heratsi" Hospital Complex #1, Yerevan State Medical University, 2 Koryun Street, Yerevan 375025, Armenia.
  3. Hamayak Sisakian: Clinic of General and Invasive Cardiology, "Heratsi" Hospital Complex #1, Yerevan State Medical University, 2 Koryun Street, Yerevan 375025, Armenia. ORCID

Abstract

Heart failure with reduced ejection fraction (HFrEF) is considered a major health care problem with frequent decompensations, high hospitalization and mortality rates. In severe heart failure (HF), the symptoms are refractory to medical treatment and require advanced therapeutic strategies. Early recognition of HF sub- and decompensation is the cornerstone of the timely treatment intensification and, therefore, improvement in the prognosis. Echocardiography is the gold standard for the assessment of systolic and diastolic functions. It allows one to obtain accurate and non-invasive measurements of the ventricular function in HF. In severely compromised HF patients, advanced cardiovascular ultrasound modalities may provide a better assessment of intracardiac hemodynamic changes and subclinical congestion. Particularly, cardiovascular and lung ultrasound allow us to make a more accurate diagnosis of subclinical congestion in HFrEF. The aim of this review was to summarize the advantages and limitations of the currently available ultrasound modalities in the ambulatory monitoring of patients with HFrEF.

Keywords

References

  1. Heart. 2013 Aug;99(15):1078-86 [PMID: 23376947]
  2. Curr Med Res Opin. 2019 Apr;35(4):705-713 [PMID: 30185067]
  3. Eur J Heart Fail. 2019 Jun;21(6):770-778 [PMID: 30919549]
  4. Clin Cardiol. 2018 Apr;41(4):510-517 [PMID: 29664116]
  5. Am J Cardiol. 1990 Aug 15;66(4):493-6 [PMID: 2386120]
  6. Circulation. 2000 Oct 10;102(15):1788-94 [PMID: 11023933]
  7. Circulation. 2009 Sep 22;120(12):1141-63 [PMID: 19720935]
  8. Card Fail Rev. 2017 Apr;3(1):7-11 [PMID: 28785469]
  9. Eur J Heart Fail. 2014 Oct;16(10):1089-95 [PMID: 25044440]
  10. JACC Cardiovasc Imaging. 2013 Jan;6(1):16-28 [PMID: 23328557]
  11. J Cardiovasc Imaging. 2020 Apr;28(2):137-149 [PMID: 32233166]
  12. J Am Soc Echocardiogr. 2016 Apr;29(4):277-314 [PMID: 27037982]
  13. Eur J Heart Fail. 2010 May;12(5):423-33 [PMID: 20354029]
  14. Intensive Care Med. 2012 Apr;38(4):577-91 [PMID: 22392031]
  15. Cureus. 2017 Apr 18;9(4):e1174 [PMID: 28533992]
  16. Eur Heart J. 2016 Jul 14;37(27):2129-2200 [PMID: 27206819]
  17. Am Heart J. 2003 Oct;146(4):705-12 [PMID: 14564327]
  18. Circ Cardiovasc Imaging. 2010 May;3(3):249-56 [PMID: 20233858]
  19. ESC Heart Fail. 2021 Feb;8(1):566-576 [PMID: 33230957]
  20. Eur Heart J. 2016 Apr 14;37(15):1244-51 [PMID: 26819225]
  21. J Am Coll Cardiol. 2006 Jan 3;47(1):85-90 [PMID: 16386669]
  22. Circ Cardiovasc Imaging. 2018 Nov;11(11):e007696 [PMID: 30571318]
  23. Echocardiography. 2017 May;34(5):662-667 [PMID: 28295604]
  24. Heart Fail Rev. 2016 Jan;21(1):65-76 [PMID: 26687372]
  25. Eur J Heart Fail. 2021 Nov;23(11):1831-1840 [PMID: 34632680]
  26. Circulation. 2017 Feb 28;135(9):825-838 [PMID: 28039229]
  27. Echo Res Pract. 2018 Jun;5(2):R65-R79 [PMID: 29691224]
  28. Eur J Heart Fail. 2019 Feb;21(2):137-155 [PMID: 30600580]
  29. Card Fail Rev. 2019 Feb;5(1):44-49 [PMID: 30847245]
  30. ESC Heart Fail. 2020 Oct;7(5):2268-2277 [PMID: 32692489]
  31. Eur J Heart Fail. 2015 Nov;17(11):1172-81 [PMID: 26417699]
  32. ESC Heart Fail. 2021 Jun;8(3):2144-2153 [PMID: 33751806]
  33. JACC Cardiovasc Imaging. 2015 Dec;8(12):1351-1359 [PMID: 26577264]
  34. ESC Heart Fail. 2018 Oct;5(5):800-808 [PMID: 30015405]
  35. Heart Fail Rev. 2020 Nov;25(6):937-948 [PMID: 31617033]
  36. Am J Cardiol. 2019 Jul 1;124(1):55-62 [PMID: 31047653]
  37. PLoS One. 2019 Dec 2;14(12):e0225829 [PMID: 31790492]
  38. Herz. 2014 Mar;39(2):251-7 [PMID: 23649320]
  39. Cardiovasc Ultrasound. 2015 Sep 04;13:40 [PMID: 26337295]
  40. J Am Soc Echocardiogr. 2011 Dec;24(12):1319-24 [PMID: 21885245]
  41. Echocardiography. 2012 Mar;29(3):291-7 [PMID: 22066887]
  42. J Am Coll Cardiol. 2004 May 5;43(9):1590-5 [PMID: 15120816]
  43. Curr Heart Fail Rep. 2009 Dec;6(4):287-92 [PMID: 19948098]
  44. J Thorac Dis. 2015 Dec;7(12):2165-71 [PMID: 26793337]
  45. Eur J Heart Fail. 2010 Oct;12(10):1076-84 [PMID: 20805094]
  46. Am J Cardiol. 2015 Oct 15;116(8):1224-8 [PMID: 26279108]
  47. Circ Heart Fail. 2016 Oct;9(10): [PMID: 27656000]
  48. J Am Coll Cardiol. 2012 Jan 10;59(2):97-104 [PMID: 22222071]
  49. J Cardiovasc Ultrasound. 2011 Dec;19(4):169-73 [PMID: 22259658]
  50. J Heart Lung Transplant. 2013 Mar;32(3):333-40 [PMID: 23415315]
  51. Eur Heart J Cardiovasc Imaging. 2015 Feb;16(2):217-24 [PMID: 25552469]
  52. J Am Soc Echocardiogr. 2010 Jul;23(7):685-713; quiz 786-8 [PMID: 20620859]
  53. Handb Exp Pharmacol. 2017;243:15-33 [PMID: 27718059]
  54. J Nucl Med. 2015 Jun;56 Suppl 4:31S-38S [PMID: 26033901]
  55. Eur Heart J Cardiovasc Imaging. 2017 Sep 01;18(9):961-968 [PMID: 28444160]
  56. Eur Heart J. 2016 Jul 14;37(27):2097-104 [PMID: 27174289]
  57. Eur J Cardiovasc Nurs. 2015 Aug;14(4):286-93 [PMID: 25122616]
  58. Circulation. 2007 Oct 2;116(14):1549-54 [PMID: 17846286]
  59. JACC Heart Fail. 2019 Sep;7(9):808-817 [PMID: 31401099]
  60. J Am Coll Cardiol. 2013 Oct 15;62(16):e147-239 [PMID: 23747642]
  61. Eur Heart J. 2021 Sep 21;42(36):3599-3726 [PMID: 34447992]
  62. Heart. 2016 Jan;102(1):29-34 [PMID: 26438785]
  63. Int J Cardiol. 2014 Oct 20;176(3):611-7 [PMID: 25156856]
  64. Eur J Echocardiogr. 2011 Nov;12(11):857-64 [PMID: 21890470]
  65. ESC Heart Fail. 2021 Aug;8(4):2473-2484 [PMID: 34110099]
  66. Int J Cardiol. 2017 Aug 1;240:271-278 [PMID: 28606680]
  67. J Am Coll Cardiol. 2012 Aug 7;60(6):521-8 [PMID: 22858287]
  68. Eur Heart J Cardiovasc Imaging. 2017 Dec 01;18(12):1301-1310 [PMID: 29045589]
  69. Eur J Heart Fail. 2017 Dec;19(12):1651-1660 [PMID: 28984057]
  70. JACC Heart Fail. 2014 Apr;2(2):148-58 [PMID: 24720923]
  71. Eur J Heart Fail. 2011 Dec;13(12):1340-8 [PMID: 21990340]
  72. Am Heart J. 2006 Mar;151(3):730-5 [PMID: 16504642]
  73. Eur J Echocardiogr. 2003 Dec;4(4):262-71 [PMID: 14611821]
  74. Heart. 2020 Dec;106(24):1934-1939 [PMID: 32571960]
  75. Int J Cardiovasc Imaging. 2014 Oct;30(7):1289-95 [PMID: 24939288]
  76. J Am Coll Cardiol. 2016 Dec 6;68(22):2425-2436 [PMID: 27908347]
  77. Arch Cardiovasc Dis. 2008 Jul-Aug;101(7-8):465-73 [PMID: 18848689]

Word Cloud

Created with Highcharts 10.0.0HFultrasoundfailureHFrEFHeartreducedejectionfractionhearttreatmentadvancedassessmentaccurateventricularpatientscardiovascularmodalitiessubclinicalcongestionlungmonitoringEjectionconsideredmajorhealthcareproblemfrequentdecompensationshighhospitalizationmortalityratesseveresymptomsrefractorymedicalrequiretherapeuticstrategiesEarlyrecognitionsub-decompensationcornerstonetimelyintensificationthereforeimprovementprognosisEchocardiographygoldstandardsystolicdiastolicfunctionsallowsoneobtainnon-invasivemeasurementsfunctionseverelycompromisedmayprovidebetterintracardiachemodynamicchangesParticularlyallowusmakediagnosisaimreviewsummarizeadvantageslimitationscurrentlyavailableambulatoryFailureReducedFraction:RoleCardiovascularLungUltrasoundbeyondFractionechocardiographyinferiorvenacavaleftfillingpressureoutpatient

Similar Articles

Cited By